TREATMENT
RAF/MEK clamp inhibitor plus cetuximab achieves response in rare RAF1-mutated mCRCA case report describes a patient with RAF1 S257L-mutated, anti-EGFR-refractory metastatic CRC who achieved radiographic response and performance status improvement with avutometinib (RAF/MEK clamp inhibitor) plus cetuximab. (Oncologist)